Which should you use: StockEyes or TipRanks?
Use TipRanks if you want analyst intelligence: consensus ratings, price targets, and, distinctively, each analyst's measured track record. Its core insight is accountability: anyone can publish a rating, so TipRanks scores the raters. Use StockEyes if you want ownership intelligence: 13F filings showing which professional managers hold a stock, how positions changed last quarter, and cluster buying across managers, plus Form 4 insider reading. TipRanks aggregates opinions about stocks; StockEyes aggregates disclosed positions in stocks. The two datasets answer different questions, and serious researchers often want both.
The one-sentence distinction: TipRanks tells you what Wall Street expects. StockEyes tells you what institutions actually did, as filed with the SEC. Expectations and positions disagree often enough that checking both is a research upgrade over either alone.
What each product actually does
TipRanks collects financial data from many sources into unified stock pages: analyst ratings and price targets, insider trading, hedge fund holdings, news sentiment, and blogger opinions. Its signature feature is analyst performance tracking: every published rating is recorded, and the analyst's historical accuracy becomes a public track record. The Smart Score compresses multiple factors (analyst ratings, insider activity, hedge fund activity, technicals, and more) into a single 1-10 rating for quick comparison. TipRanks covers stocks, ETFs, and cryptocurrencies, and its data is integrated into platforms at major brokerages and market-data sites, which is meaningful third-party validation of the dataset.
StockEyes is narrower and filing-first. It organizes 13F institutional-ownership data into free per-ticker pages (which managers hold the stock, position sizes, quarterly changes), offers a 13F change screener and a cluster-buying screener as signed-in Pro tools, maintains a manager directory, and teaches Form 4 insider reading through a full evidence-first lesson. It also runs a verified market-news hub, an events calendar, and a glossary. StockEyes does not aggregate analyst ratings, does not score analysts, and does not cover crypto or forex; its universe is U.S.-listed equities and the filings around them.
Both products are aggregators, but the aggregation philosophies differ. TipRanks synthesizes many soft signals (opinions, sentiment, scores) into consensus views. StockEyes structures hard filings (13F, Form 4) into researchable datasets. Neither philosophy is wrong; they serve different stages of research.
Analyst data: TipRanks’ home turf
This is the dimension TipRanks owns, and StockEyes does not contest it. TipRanks' analyst pages show each analyst's rating history alongside a measured track record, so a recommendation arrives with its author's batting average. The consensus view (how many analysts rate a stock buy, hold, or sell, and where price targets cluster) is the standard starting point for "what does Wall Street think," and TipRanks presents it cleanly. The Smart Score adds a quantitative overlay for investors who want a single number to sort by, though any composite score deserves the same skepticism as any other: it is a screening filter, not a verdict.
StockEyes publishes no analyst ratings, no price targets, and no analyst track records. If your process starts with sell-side consensus, or if you specifically want to find the analysts with the best historical accuracy in a sector and weight their views accordingly, TipRanks is the tool and StockEyes has nothing to offer on that job. Stating that plainly is the point of a fair comparison.
The honest caveat about analyst data in general: ratings skew positive (sell ratings are rare), price targets move with prices, and even the best-tracked analysts are wrong regularly. TipRanks' track records mitigate the first problem by exposing who deserves attention; they cannot fix the structural optimism of sell-side research. Use the consensus as one input, and check it against harder evidence, which is where ownership data earns its place.
Ownership data: StockEyes’ home turf
TipRanks does cover ownership: its stock pages include insider trading data and hedge fund holdings alongside the analyst material. For a quick read on whether insiders are buying or which hedge funds hold a name, that coverage is convenient. But ownership is one tab among many on TipRanks, not the product's center of gravity. It does not offer manager-level 13F change screening, multi-quarter holder history per ticker, or cluster-buying detection across managers.
StockEyes is built around exactly that. Its free institutional-ownership pages show which managers hold each ticker and how their positions changed quarter over quarter from 13F filings. The Pro 13F change screener filters the full dataset by holder-count changes, share-count changes, and position values; the cluster-buying screener finds managers increasing reported positions across several tickers simultaneously. The manager directory lets you study individual managers' reported portfolios. For investors whose process is "follow the smart money through its filings," this is a deeper toolkit than TipRanks' ownership tab.
On insider trading specifically, the comparison is closer. TipRanks aggregates insider transactions into its stock pages; StockEyes pairs insider data with its Form 4 reading lesson, which teaches transaction codes, 10b5-1 plan disclosures, and cluster-buy logic. If you want insider data embedded in a broad dashboard, TipRanks is convenient. If you want to learn to read the filings yourself and verify signals against the original Form 4, StockEyes' lesson-first approach goes further.
| Capability | TipRanks | StockEyes |
|---|---|---|
| Analyst ratings and price targets | Core product, with consensus views | Not offered |
| Analyst track records | Signature feature: measured accuracy per analyst | Not offered |
| 13F manager-level holdings | Hedge fund holdings shown on stock pages | Free per-ticker pages with manager detail |
| Quarterly 13F change screening | Not offered | Dedicated screener (Pro) |
| Cluster buying across managers | Not offered | Dedicated screener (Pro) |
| Insider transactions (Form 4) | Aggregated on stock pages | Aggregated plus a full reading lesson |
| Composite stock score | Smart Score (1-10) | Not offered; filing evidence instead |
Screening tools compared
TipRanks' screeners filter by analyst consensus, upside to price target, dividend yield, Smart Score, and other criteria, and its ETF screener covers thousands of funds by holdings, performance, and expense data. The screening philosophy is consensus-first: find stocks the analysts like, with the metrics to back the screen. For investors who trust the sell-side consensus as a starting filter, these screeners are well designed.
StockEyes' screeners are filing-first: the 13F change screener finds stocks by what changed in institutional ownership last quarter, and the cluster-buying screener finds managers accumulating across names. The philosophy is behavior-first: find stocks that professional money is actually buying, as disclosed in filings, regardless of what analysts say. The two philosophies produce different watchlists, which is precisely why using both is informative: a stock that screens well on analyst consensus and shows fresh institutional accumulation is a stronger research lead than one that shows only one of the two.
Neither product is a Finviz-style general technical screener. TipRanks has technical factors inside its Smart Score and screening, and StockEyes has no technical screening at all. If chart-based pattern screening is the job, neither is the best tool; see the Finviz comparison for that dimension.
Pricing compared
TipRanks has a free Basic tier covering core stock pages, analyst ratings, and screening tools, and paid tiers for deeper access. The list pricing shown on its site has recently been around $29.95 per month for Premium (billed annually at $359) and around $49.95 per month for Ultimate (billed annually at $599), with Premium adding the full Smart Score, top-analyst filters, portfolio research, and alerts, and Ultimate adding benchmark-relative analyst rankings, full expert rankings, and unlimited alerts. TipRanks runs frequent promotions that discount the first year substantially, and a 30-day money-back guarantee applies to website purchases. As always, check the current pricing page before subscribing, since list prices and promotions change.
StockEyes keeps its institutional-ownership pages, market news, events calendar, glossary, and learn lessons free, with the 13F change screener, cluster-buying screener, manager detail, and comparison tools on the signed-in Pro tier. There is no analyst-data paid tier because there is no analyst-data product; the paid layer exists only around institutional-ownership research.
Price check note: TipRanks prices above reflect its public plans page as reported in independent reviews in September and October 2026. Promotional pricing is common; verify the checkout total before you pay.
Who each tool is best for
Choose TipRanks if you research through analysts
You want to know what Wall Street thinks, which analysts have earned attention with real track records, and where price targets cluster. You like consensus data and composite scores as screening starting points, and you want ETFs, portfolio tools, and alerts in the same product. TipRanks is the broader, more mainstream research dashboard.
Choose StockEyes if you research through filings
You trust disclosed positions more than published opinions. Your process is: check the 13F data for who owns the stock and what changed, check Form 4s for insider confirmation, then read the business filings. You are comfortable with quarterly data and you want the evidence trail, not a score.
Use both when they disagree
The most informative setup is running both lenses on the same stock: strong analyst consensus plus fresh institutional accumulation is a convergence worth researching; strong consensus with institutions selling is a divergence worth understanding before you act. Disagreement between opinions and positions is often where the real research question lives.
Questions about StockEyes vs TipRanks
Is TipRanks free?
TipRanks offers a free Basic tier with core stock pages, analyst ratings, and screening tools. Paid tiers, Premium and Ultimate, add the full Smart Score, top-analyst filters, portfolio research, deeper insider and hedge fund data, and more alerts.
What is the TipRanks Smart Score?
The Smart Score is TipRanks’ 1-10 composite rating combining analyst ratings, insider activity, hedge fund activity, technical indicators, and other factors. Treat it as a screening filter and starting point, not a verdict; StockEyes takes the opposite approach, presenting filing evidence without a composite score.
Does TipRanks show 13F data?
TipRanks shows hedge fund holdings and insider trading on its stock pages, but it does not offer manager-level 13F change screening or cluster-buying detection. For dedicated 13F research, StockEyes’ ownership pages and Pro screeners go deeper.
Does StockEyes have analyst ratings?
No. StockEyes does not aggregate analyst ratings, price targets, or analyst track records. Its research datasets are SEC filings: 13F institutional ownership and Form 4 insider transactions, plus market news and events.
How much does TipRanks Premium cost?
List pricing recently shown on TipRanks’ site was about $29.95 per month for Premium billed annually ($359/year) and about $49.95 per month for Ultimate billed annually ($599/year), with frequent first-year promotions and a 30-day money-back guarantee. Verify current pricing at checkout.
Can analyst track records be trusted?
TipRanks’ track records are measured from published ratings, which is a genuine accountability improvement over anonymous consensus. But past recommendation performance does not guarantee future results, ratings skew positive structurally, and even top-ranked analysts are wrong regularly. Use track records to weight opinions, not to replace your own research.
StockEyes provides informational research organization and transparent calculations, not personalized investment advice, valuation conclusions, trade instructions, or predictions. Data described here reflects the sources and dates noted in the article; verify current pricing, features, and data coverage on each provider’s site before subscribing. Consult a qualified professional for advice about your own situation.